American pharmaceutical companies United Therapeutics and Liquidia are in a heated legal battle over patent validity. Both companies have their own Treprostinil drugs—United’s brand being Tyvaso, and Liquidia’s generic form being Yutrepia. Both are used to treat certain forms of Pulmonary Hypertension (PH), but Yutrepia has yet to hit the market. […]
A Pharma Patent Battle and The Risk of Intellectual Property Liability
